Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bjørnevik K[au]:

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease. Mittal S et al. Science. (2017)

Urate and the risk of Parkinson's disease in men and women. Cortese M et al. Parkinsonism Relat Disord. (2018)

Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Bjornevik K et al. Neurology. (2019)

Search results

Items: 26

1.

Big health data and Parkinson's disease epidemiology: Challenges and opportunities.

Bjornevik K, Schwarzschild MA, Ascherio A.

Parkinsonism Relat Disord. 2020 Feb;71:58-59. doi: 10.1016/j.parkreldis.2020.01.001. Epub 2020 Jan 7. No abstract available.

PMID:
31948788
2.

Prediagnostic plasma polyunsaturated fatty acids and the risk of amyotrophic lateral sclerosis.

O'Reilly ÉJ, Bjornevik K, Furtado JD, Kolonel LN, Le Marchand L, McCullough ML, Stevens VL, Shadyab AH, Snetselaar L, Manson JE, Ascherio A.

Neurology. 2020 Feb 25;94(8):e811-e819. doi: 10.1212/WNL.0000000000008676. Epub 2019 Dec 3.

PMID:
31796528
3.

Ultra-processed food consumption during childhood and asthma in adolescence: Data from the 2004 Pelotas birth cohort study.

Machado Azeredo C, Cortese M, Costa CDS, Bjornevik K, Barros AJD, Barros FC, Santos IS, Matijasevich A.

Pediatr Allergy Immunol. 2020 Jan;31(1):27-37. doi: 10.1111/pai.13126. Epub 2019 Oct 8.

PMID:
31541568
4.

Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis.

Bjornevik K, Munger KL, Cortese M, Barro C, Healy BC, Niebuhr DW, Scher AI, Kuhle J, Ascherio A.

JAMA Neurol. 2019 Sep 13. doi: 10.1001/jamaneurol.2019.3238. [Epub ahead of print]

PMID:
31515562
5.

Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis.

Bjornevik K, Zhang Z, O'Reilly ÉJ, Berry JD, Clish CB, Deik A, Jeanfavre S, Kato I, Kelly RS, Kolonel LN, Liang L, Marchand LL, McCullough ML, Paganoni S, Pierce KA, Schwarzschild MA, Shadyab AH, Wactawski-Wende J, Wang DD, Wang Y, Manson JE, Ascherio A.

Neurology. 2019 Apr 30;92(18):e2089-e2100. doi: 10.1212/WNL.0000000000007401. Epub 2019 Mar 29.

PMID:
30926684
6.

Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study.

Magalhaes S, Pugliatti M, Riise T, Myhr KM, Ciampi A, Bjornevik K, Wolfson C.

Int J Epidemiol. 2019 Aug 1;48(4):1073-1082. doi: 10.1093/ije/dyy269.

PMID:
30561654
7.

Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis.

Bjornevik K, O'Reilly ÉJ, Berry JD, Clish CB, Jeanfavre S, Kato I, Kolonel LN, Le Marchand L, McCullough ML, Paganoni S, Schwarzschild MA, Talbott EO, Wallace RB, Zhang Z, Manson JE, Ascherio A.

Neurology. 2019 Apr 30;92(18):e2081-e2088. doi: 10.1212/WNL.0000000000006669. Epub 2018 Nov 14.

PMID:
30429276
8.

Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System.

Antonazzo IC, Poluzzi E, Forcesi E, Riise T, Bjornevik K, Baldin E, Muratori L, De Ponti F, Raschi E.

Mult Scler. 2019 Oct;25(12):1633-1640. doi: 10.1177/1352458518799598. Epub 2018 Sep 19.

PMID:
30230957
9.

Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System.

Antonazzo IC, Raschi E, Forcesi E, Riise T, Bjornevik K, Baldin E, De Ponti F, Poluzzi E.

Expert Opin Drug Saf. 2018 Sep;17(9):869-874. doi: 10.1080/14740338.2018.1506763. Epub 2018 Aug 11.

PMID:
30058390
10.

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients.

Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø.

Mult Scler. 2019 Jun;25(7):987-993. doi: 10.1177/1352458518779925. Epub 2018 Jun 4.

PMID:
29862891
11.

Urate and the risk of Parkinson's disease in men and women.

Cortese M, Riise T, Engeland A, Ascherio A, Bjørnevik K.

Parkinsonism Relat Disord. 2018 Jul;52:76-82. doi: 10.1016/j.parkreldis.2018.03.026. Epub 2018 Mar 28.

PMID:
29615298
12.

Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis.

O'Reilly ÉJ, Bjornevik K, Schwarzschild MA, McCullough ML, Kolonel LN, Le Marchand L, Manson JE, Ascherio A.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):194-200. doi: 10.1080/21678421.2017.1418005. Epub 2017 Dec 26.

13.

Diabetes is associated with decreased migraine risk: A nationwide cohort study.

Antonazzo IC, Riise T, Cortese M, Berge LI, Engeland A, Bernt Fasmer O, Lund A, Joachim Ødegaard K, Poluzzi E, Bjornevik K.

Cephalalgia. 2018 Oct;38(11):1759-1764. doi: 10.1177/0333102417748573. Epub 2017 Dec 17.

PMID:
29249165
14.

Neurofilament light chain predicts disease activity in relapsing-remitting MS.

Varhaug KN, Barro C, Bjørnevik K, Myhr KM, Torkildsen Ø, Wergeland S, Bindoff LA, Kuhle J, Vedeler C.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 28;5(1):e422. doi: 10.1212/NXI.0000000000000422. eCollection 2018 Jan.

15.

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.

Mittal S, Bjørnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Schüle B, Park DS, Riise T, Scherzer CR.

Science. 2017 Sep 1;357(6354):891-898. doi: 10.1126/science.aaf3934.

16.

Body size and physical exercise, and the risk of multiple sclerosis.

Cortese M, Riise T, Bjørnevik K, Myhr KM; Multiple Sclerosis Conscript Service Database Study Group.

Mult Scler. 2018 Mar;24(3):270-278. doi: 10.1177/1352458517699289. Epub 2017 Mar 13.

PMID:
28287051
17.

Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study.

Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K.

Mult Scler. 2018 Feb;24(2):150-157. doi: 10.1177/1352458517694088. Epub 2017 Feb 1.

PMID:
28273774
18.

Polyunsaturated fatty acids and the risk of multiple sclerosis.

Bjørnevik K, Chitnis T, Ascherio A, Munger KL.

Mult Scler. 2017 Dec;23(14):1830-1838. doi: 10.1177/1352458517691150. Epub 2017 Feb 3.

19.

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2017 Jun;23(7):1018-1024. doi: 10.1177/1352458516671028. Epub 2016 Sep 23.

PMID:
27663872
20.

Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom.

Cortese M, Riise T, Bjørnevik K, Bhan A, Farbu E, Grytten N, Hogenesch I, Midgard R, Smith Simonsen C, Telstad W, Ascherio A, Myhr KM.

Ann Neurol. 2016 Oct;80(4):616-24. doi: 10.1002/ana.24769.

PMID:
27554176
21.

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.

Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N.

Mult Scler. 2017 Feb;23(2):213-219. doi: 10.1177/1352458516646863. Epub 2016 Jul 11.

22.

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.

Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M.

Mult Scler. 2016 Jan;22(1):104-11. doi: 10.1177/1352458515579444. Epub 2015 May 26.

23.

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.

Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2015 Dec;21(14):1856-64. doi: 10.1177/1352458515578770. Epub 2015 May 6.

24.

Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study.

Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM.

Mult Scler. 2015 Apr;21(4):388-95. doi: 10.1177/1352458514546785. Epub 2014 Sep 2.

PMID:
25182290
25.

Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study.

Bjørnevik K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Pugliatti M.

Mult Scler. 2014 Jul;20(8):1042-9. doi: 10.1177/1352458513513968. Epub 2014 Jan 10.

PMID:
24414538
26.

Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.

Lossius A, Riise T, Pugliatti M, Bjørnevik K, Casetta I, Drulovic J, Granieri E, Kampman MT, Landtblom AM, Lauer K, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Holmøy T.

Mult Scler. 2014 May;20(6):669-74. doi: 10.1177/1352458513505693. Epub 2013 Sep 26.

PMID:
24072723

Supplemental Content

Loading ...
Support Center